NM_014363.6:c.7140T>A

Variant summary

Our verdict is Likely benign. The variant received -3 ACMG points: 0P and 3B. BP4_ModerateBP6

The NM_014363.6(SACS):​c.7140T>A​(p.Asn2380Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000267 in 1,613,760 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00017 ( 0 hom., cov: 33)
Exomes 𝑓: 0.00028 ( 0 hom. )

Consequence

SACS
NM_014363.6 missense

Scores

3
6
9

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:6B:3

Conservation

PhyloP100: 1.45

Publications

4 publications found
Variant links:
Genes affected
SACS (HGNC:10519): (sacsin molecular chaperone) This gene encodes the sacsin protein, which includes a UbL domain at the N-terminus, a DnaJ domain, and a HEPN domain at the C-terminus. The gene is highly expressed in the central nervous system, also found in skin, skeletal muscles and at low levels in the pancreas. This gene includes a very large exon spanning more than 12.8 kb. Mutations in this gene result in autosomal recessive spastic ataxia of Charlevoix-Saguenay (ARSACS), a neurodegenerative disorder characterized by early-onset cerebellar ataxia with spasticity and peripheral neuropathy. The authors of a publication on the effects of siRNA-mediated sacsin knockdown concluded that sacsin protects against mutant ataxin-1 and suggest that "the large multi-domain sacsin protein is able to recruit Hsp70 chaperone action and has the potential to regulate the effects of other ataxia proteins" (Parfitt et al., PubMed: 19208651). A pseudogene associated with this gene is located on chromosome 11. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, May 2013]
SACS Gene-Disease associations (from GenCC):
  • Charlevoix-Saguenay spastic ataxia
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine, PanelApp Australia, G2P, Myriad Women’s Health, Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Likely_benign. The variant received -3 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.24251121).
BP6
Variant 13-23336736-A-T is Benign according to our data. Variant chr13-23336736-A-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 285241.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_014363.6. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SACS
NM_014363.6
MANE Select
c.7140T>Ap.Asn2380Lys
missense
Exon 10 of 10NP_055178.3
SACS
NM_001437336.1
c.7167T>Ap.Asn2389Lys
missense
Exon 11 of 11NP_001424265.1A0A804HIQ1
SACS
NM_001278055.2
c.6699T>Ap.Asn2233Lys
missense
Exon 8 of 8NP_001264984.1

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SACS
ENST00000382292.9
TSL:5 MANE Select
c.7140T>Ap.Asn2380Lys
missense
Exon 10 of 10ENSP00000371729.3Q9NZJ4-1
SACS
ENST00000455470.6
TSL:1
c.2431+4709T>A
intron
N/AENSP00000406565.2H0Y6M8
SACS
ENST00000682944.1
c.7167T>Ap.Asn2389Lys
missense
Exon 11 of 11ENSP00000507173.1A0A804HIQ1

Frequencies

GnomAD3 genomes
AF:
0.000171
AC:
26
AN:
152144
Hom.:
0
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.0000241
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000458
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0000882
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000284
AC:
71
AN:
250434
AF XY:
0.000288
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.0000869
Gnomad ASJ exome
AF:
0.00358
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.000265
Gnomad OTH exome
AF:
0.000329
GnomAD4 exome
AF:
0.000277
AC:
405
AN:
1461616
Hom.:
0
Cov.:
37
AF XY:
0.000257
AC XY:
187
AN XY:
727114
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33472
American (AMR)
AF:
0.0000895
AC:
4
AN:
44702
Ashkenazi Jewish (ASJ)
AF:
0.00352
AC:
92
AN:
26126
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39684
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86246
European-Finnish (FIN)
AF:
0.0000187
AC:
1
AN:
53356
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.000254
AC:
282
AN:
1111876
Other (OTH)
AF:
0.000431
AC:
26
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
25
50
74
99
124
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000171
AC:
26
AN:
152144
Hom.:
0
Cov.:
33
AF XY:
0.000148
AC XY:
11
AN XY:
74326
show subpopulations
African (AFR)
AF:
0.0000241
AC:
1
AN:
41416
American (AMR)
AF:
0.000458
AC:
7
AN:
15270
Ashkenazi Jewish (ASJ)
AF:
0.00346
AC:
12
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5206
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4834
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
10612
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
316
European-Non Finnish (NFE)
AF:
0.0000882
AC:
6
AN:
68014
Other (OTH)
AF:
0.00
AC:
0
AN:
2092
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.494
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000737
Hom.:
1
Bravo
AF:
0.000280
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000465
AC:
4
ExAC
AF:
0.000264
AC:
32
EpiCase
AF:
0.000273
EpiControl
AF:
0.000297

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
4
-
not provided (4)
-
2
-
Charlevoix-Saguenay spastic ataxia (2)
-
-
1
Inborn genetic diseases (1)
-
-
1
not specified (1)
-
-
1
Spastic paraplegia (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
0.81
BayesDel_addAF
Benign
-0.20
T
BayesDel_noAF
Benign
-0.22
CADD
Benign
14
DANN
Benign
0.92
DEOGEN2
Benign
0.13
T
Eigen
Benign
-0.30
Eigen_PC
Benign
-0.33
FATHMM_MKL
Uncertain
0.81
D
LIST_S2
Uncertain
0.96
D
M_CAP
Uncertain
0.28
D
MetaRNN
Benign
0.24
T
MetaSVM
Uncertain
-0.21
T
MutationAssessor
Uncertain
2.1
M
PhyloP100
1.5
PrimateAI
Uncertain
0.75
T
PROVEAN
Benign
0.22
N
REVEL
Pathogenic
0.75
Sift
Benign
0.40
T
Sift4G
Pathogenic
0.0
D
Polyphen
0.80
P
Vest4
0.77
MutPred
0.39
Gain of methylation at N2380 (P = 0.0062)
MVP
0.77
ClinPred
0.064
T
GERP RS
-0.60
Varity_R
0.14
gMVP
0.43
Mutation Taster
=68/32
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs61754478; hg19: chr13-23910875; API